Cargando…
Use of dexmedetomidine to alleviate intestinal ischemia-reperfusion injury via intestinal microbiota modulation in mice
BACKGROUND: Intestinal ischemia-reperfusion (I/R) injury is a serious condition with unacceptable mortality rates. Our previous study revealed a protective effect of dexmedetomidine (DEX) on intestinal I/R injury, but its underlying mechanism remains unclear. Gut microbiota imbalance is associated w...
Autores principales: | Dong, Ye-Hong, Hu, Jing-Juan, Deng, Fan, Chen, Xiao-Dong, Li, Cai, Liu, Ke-Xuan, Zhao, Bing-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708495/ https://www.ncbi.nlm.nih.gov/pubmed/36467356 http://dx.doi.org/10.21037/atm-22-824 |
Ejemplares similares
-
Pretreatment with dexmedetomidine alleviates lung injury in a rat model of intestinal ischemia reperfusion
por: Chen, Yaping, et al.
Publicado: (2020) -
The role of intestinal microbiota and its metabolites in intestinal and extraintestinal organ injury induced by intestinal ischemia reperfusion injury
por: Deng, Fan, et al.
Publicado: (2022) -
Irisin Contributes to the Hepatoprotection of Dexmedetomidine during Intestinal Ischemia/Reperfusion
por: Fan, Xin, et al.
Publicado: (2019) -
Effect of dexmedetomidine pretreatment on lung injury following intestinal ischemia-reperfusion
por: SHEN, JINMEI, et al.
Publicado: (2013) -
Dynamic Alteration of the Colonic Microbiota in Intestinal Ischemia-Reperfusion Injury
por: Wang, Fan, et al.
Publicado: (2012)